Monday, February 12, 2024
7:00 AM – 8:00 AM
Cherry Blossom Ballroom,
This independent presentation is not part of the official program as planned by the SMFM Pregnancy Meeting™ Program Committee.
This thought-provoking symposium on preeclampsia convenes leading experts: Olympic champion and maternal health advocate Allyson Felix; Thomas McElrath, a renowned figure in translational medicine in pregnancy; Maged Costantine, a distinguished maternal-fetal medicine specialist and researcher; and Melissa J. Moore, a respected authority in RNA science. Allison August, Chief Medical Officer of Comanche Biopharma, will moderate the event.
The program is designed to deepen the understanding of preeclampsia’s complexities among clinicians. It will facilitate a scientific exchange on the latest research and scientific advancements, aiming to foster collaborative efforts in advancing solutions to address this urgent maternal health issue.
Comprehend the role of sFlt-1 in the pathophysiology of preeclampsia and the implications for diagnosis and treatment.
Recognize the value of the available diagnostic tests for early detection and monitoring of preeclampsia.
Appreciate the clinician’s perspective in using the diagnostic test to diagnose and manage preeclampsia and optimizing patient care.
Understand how siRNA therapeutics work and the potential of an siRNA therapeutic as a treatment option for preeclampsia.
Be aware of the patient’s perspective and the impacts of preeclampsia.